- Home
- MAA vs ASND Comparison
MAA vs ASND Comparison
Compare MAA & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MAA | ASND |
|---|---|---|
| Founded | 1977 | 2006 |
| Country | United States | Denmark |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.8B | 13.6B |
| IPO Year | N/A | 2014 |
Fundamental Metrics
Financial Performance| Metric | MAA | ASND |
|---|---|---|
| Price | $122.93 | $219.01 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 18 | 16 |
| Target Price | $149.33 | ★ $279.50 |
| AVG Volume (30 Days) | ★ 738.1K | 598.9K |
| Earning Date | 04-29-2026 | 04-30-2026 |
| Dividend Yield | ★ 5.03% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $2.85 | $98.57 |
| Revenue Next Year | $3.13 | $43.22 |
| P/E Ratio | $35.71 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $121.22 | $124.06 |
| 52 Week High | $169.42 | $248.60 |
Technical Indicators
Market Signals| Indicator | MAA | ASND |
|---|---|---|
| Relative Strength Index (RSI) | 29.62 | 40.17 |
| Support Level | N/A | $189.53 |
| Resistance Level | $136.72 | $222.47 |
| Average True Range (ATR) | 2.32 | 7.05 |
| MACD | -0.82 | -2.23 |
| Stochastic Oscillator | 12.89 | 6.24 |
Price Performance
Historical ComparisonAbout MAA Mid-America Apartment Communities Inc.
Mid-America Apartment Communities Inc is a multifamily-focused, self-administered and self-managed real estate investment trust. The company owns, operates, acquires and selectively develops apartment communities located in the Southeast, Southwest and Mid-Atlantic regions of the U.S. Its business objectives are to generate a sustainable, stable and increasing cash flow that will fund its dividends and distributions through all parts of the real estate investment cycle. It operates in two segments, Same Store and Non-Same Store and Other. The majority of the revenue is derived from Same Store segment.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.